| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SAPERSTEIN ANDREW M | Co-President | C/O MORGAN STANLEY, 1585 BROADWAY, NEW YORK | /s/ Martin M. Cohen, Attorney-in-Fact | 16 Jan 2026 | 0001362383 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MS | Common Stock | Award | $0 | +39,994 | +13% | $0.000000 | 338,076 | 16 Jan 2026 | Direct | F1 |
| transaction | MS | Common Stock | Tax liability | $5,213,886 | -27,265 | -8.1% | $191.23 | 310,811 | 16 Jan 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Restricted Stock Units granted in 2026 as part of 2025 year-end compensation, which are convertible to shares of Common Stock at a ratio of 1 to 1. |
| F2 | Shares withheld to satisfy taxes upon the conversion of Restricted Stock Units granted on January 18, 2023. |